A clinical pilot study on the safety and efficacy of aerosol inhalation treatment of IFN-κ plus TFF2 in patients with moderate COVID-19.
Fu W, Liu Y, Xia L, Li M, Song Z, Hu H, Yang Z, Wang L, Cheng X, Wang M, Jiang R, Liu L, Mao X, Chen J, Ling Y, Zhang L, Yan J, Shan F, Steinhart C, Zhang X, Zhu T, Xu J, Lu H.
Fu W, et al. Among authors: xia l.
EClinicalMedicine. 2020 Aug;25:100478. doi: 10.1016/j.eclinm.2020.100478. Epub 2020 Jul 29.
EClinicalMedicine. 2020.
PMID: 32838238
Free PMC article.